Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Occurence of Pain and Use of Analgesic Treatment in Multi-trauma Patients of Intermediate Seveity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03730272
Recruitment Status : Recruiting
First Posted : November 5, 2018
Last Update Posted : November 5, 2018
Sponsor:
Information provided by (Responsible Party):
Johan C Ræder, Oslo University Hospital

Brief Summary:
To register the perceived pain score during 0-14 days after multitrauma in conscious patients and to register the use (type and dose) of analgesic treatment in the same period.

Condition or disease Intervention/treatment
Post Traumatic Pain Post Traumatic Analgesic Treatment Drug: analgesic drugs and methods

Layout table for study information
Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Incidence and Strenght of Pain in Conscious Multitrauma Patients, 0-14 Days After Multitrauma
Actual Study Start Date : August 1, 2018
Estimated Primary Completion Date : March 2019
Estimated Study Completion Date : November 1, 2019

Intervention Details:
  • Drug: analgesic drugs and methods
    the patient will receive analgesic treatment at the discretion of the physician in charge


Primary Outcome Measures :
  1. Worst pain [ Time Frame: 0-14 days ]
    NRS scale, 0-10

  2. Average pain [ Time Frame: 0-14 days ]
    NRS scale, 0-10


Secondary Outcome Measures :
  1. analgesic methods [ Time Frame: 0-14 days ]
    list of drugs (dose and duration) and other analgesic measures



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Patients With any kind of multitrauma, fullfilling inclusion/exclusion
Criteria

Inclusion Criteria:

  • Patient With trauma, ISS > 8

Exclusion Criteria:

  • Unconscious patients at admission
  • patients due for major surgery within 3 hrs of admission
  • patients primary admitted to other hospitals
  • not able to communicate in Norewegian

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03730272


Locations
Layout table for location information
Norway
Dept of Anesthesiology, Oslo University Hospital, Ullevaal Recruiting
Oslo, Norway, 0407
Contact: Johan Raeder, PhD    004792249669    johan.rader@medisin.uio.no   
Sponsors and Collaborators
Oslo University Hospital

Layout table for additonal information
Responsible Party: Johan C Ræder, professor, Oslo University Hospital
ClinicalTrials.gov Identifier: NCT03730272     History of Changes
Other Study ID Numbers: Trauma.pain.Gyda
First Posted: November 5, 2018    Key Record Dates
Last Update Posted: November 5, 2018
Last Verified: November 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs